Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Completed · Phase 3 · Has a placebo group

Conditions studied: Facial Rhytides, Crow's Feet Lines, Glabellar Lines

In brief

This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides)

Key facts

Study ID

NCT01189760

Run by

Allergan

People needed

917

Starts

2010-09-01

Expected to finish

2011-09-01

Last updated by the study team

2019-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate to severe Crow's Feet Lines and Frown Lines
• Have adequate vision without the use of eyeglasses to assess facial wrinkles in the mirror (contact lenses OK)

You may not qualify if…

• Current or previous botulinum toxin treatment of any serotype
• Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis
• Prior facial cosmetic surgery (e.g., prior periorbital surgery, facial lift, brow lift, eyelid lift or eyebrow surgery)
• Facial laser or light treatment, microdermabrasion, or superficial peels within 3 months
• Oral retinoid therapy within one year

Where it is running

• Study site — Newport Beach, California, United States
• Study site — Vancouver, British Columbia, Canada
• Study site — Antibes, France
• Study site — Berlin, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.